Pharmaceutical Disclosures and IPO Insights

Scott and Ed unpack RFK Jr.’s push to make it harder, and pricier, for pharma companies to advertise directly to consumers, a move that could be the final blow to the broadcast industrial complex. Next, they explore the IPO market’s rebound and why, despite the buzz, it's a trap for retail investors. Finally, they break down the dollar’s decline since Trump took office, and why gold’s rise as a safe-haven asset isn’t enough to win them over.

Subscribe to the Prof G Markets newsletter 

Order "The Algebra of Wealth," out now

Subscribe to No Mercy / No Malice

Follow the podcast across socials @profgmarkets

Follow Scott on Instagram
Follow Ed on Instagram and X

Learn more about your ad choices. Visit podcastchoices.com/adchoices